| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025809 |
| Receipt No. | R000029248 |
| Official scientific title of the study | Effects of fermented milk drink ingestion on human blood leukocyte subsets |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2018/01/24 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effects of fermented milk drink ingestion on human blood leukocyte subsets | |
| Title of the study (Brief title) | Effects of fermented milk drink ingestion on human blood leukocytes | |
| Region |
|
|
| Condition | ||
| Condition | healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | It has been reported that disruption of gut microbiota composition (dysbiosis) is associated with pathogenesis of various diseases. Recently beneficial bacteria (probiotics) are focused on improving health, although how they affect immune cells is not fully understood. In this study, we aim to investigate whether ingestion of fermented milk drink for months affects leukocyte populations in peripheral blood in healthy human subjects. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The cell number and proportion of leukocyte subsets in the peripheral blood |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The group provided with fermented milk drink. They will take a bottle of drink (Yakult; containing Lactobacillus casei Shirota 2 x 10^10) per day for three months.
|
|
| Interventions/Control_2 | The group not provided with fermented milk drink. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy subjects recruited from high school students with age 16-18 years | |||
| Key exclusion criteria | The following subjects will be excluded;
-taking antibiotics within previous two months. -showing any infectious symptoms within previous two months. -currently contracting any chronic diseases. -taking any dietary supplements on a daily basis. -taking yogurt more than 3 times per week. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kiyoshi Takeda |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Laboratory of Immune Regulation, Department of Microbiology and Immunology |
| Address | 2-2 Yamada-oka, Suita, Osaka |
| TEL | 06-6879-3982 |
| ktakeda@ongene.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Eiji Umemoto |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Laboratory of Immune Regulation, Department of Microbiology and Immunology |
| Address | 2-2 Yamada-oka, Suita, Osaka |
| TEL | 06-6879-3982 |
| Homepage URL | |
| umemoto@ongene.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Laboratory of Immune Regulation, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Laboratory of Immune Regulation, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪大学医学系研究科(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029248 |